Canadian application, no grantCanada
Potentiation of prodrug efficacy
CA 2390975 A1 · Owner: Hybridon, Inc. · Inventors: Agrawal, Sudhir
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides methods for statistically significantly potentiating the activity of a prodrug without producing significant side effects the , method comprising co-administering a polyanion with the prodrug.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 8, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 8, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 8, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 8, 2000
GrantedNo grant recorded
Term endedNovember 8, 2020
Patent numberCA 2390975 A1
Classification (IPC)A61K45/06 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.